Topics

Medulloblastoma | Treatment | Side effects | Radiotherapy

Home > Publications > Topics > Medulloblastoma > Treatment > Side effects > Radiotherapy

Baghani HR, Porouhan P.
Secondary cancer risk assessment in healthy organs following craniospinal irradiation.
Int J Radiat Biol. 2024 Jun 18:1-9. doi: 10.1080/09553002.2024.2369110. PMID: 38889539. Laboratory investigation˰ ˍ

Abu-Arja MH, Brown AL, Su JM, Okcu MF, Lindsay HB, McGovern SL, McAleer MF, Grosshans DR, Chintagumpala MM, Paulino AC.
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
Neuro Oncol. 2024 Jun 25:noae114. doi: 10.1093/neuonc/noae114. PMID: 38916058. Observational study˰ ˍ

Diaz LS, Agrup M, Askild A, Embring A, Engellau J, Kristensen IF, Flejmer A, Fröjd C, Nilsson MP, Svärd AM, Walfridsson A, Blomstrand M.
Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05016-x. PMID: 40232619. Observational study. ˍ

Nguyen P, Indelicato DJ, Esterman A, Paulino AC, Ermoian RP, Laack NN, Perkins SM, Mangona V, Mihalcik S, Lee J, Hill-Kayser C, Kwok Y, Chang JH, Perentesis JP, MacEwan I, Le H, Yock TI.
Acute Toxicities of Proton Craniospinal Irradiation in Pediatric Medulloblastoma: A Pediatric Proton/Photon Consortium Registry (PPCR) Study.
Int J Part Ther. 2025 Apr 17;16:100747. doi: 10.1016/j.ijpt.2025.100747. PMID: 40336980. Observational study. ˍ